Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Mersana Therapeutics
840 Memorial Drive
Cambridge, MA 2139
Phone: 617-498-0020

Mersana engineers novel drug conjugates that maximize the potential of new and established therapeutic classes. Our technology harnesses the power and synergy of nanotechnology, biologics and small molecules. Mersana is advancing its own pipeline of next-generation drugs with best-in-class potential to address unmet needs and improve patient outcomes in multiple oncology indications. Utilizing our technology, we are developing a portfolio of next-generation antibody-drug conjugates (ADC) with superior properties not found with current ADC technologies.

Key Contact
Name
Nicholas G. Bacopoulos, Ph.D.
Title
CEO
E-Mail
Funding Events

Date
Amount
Type
Investors
Valuation
04/18/12 $10,000,000
07/31/12 $27,000,000 Series A-1 Harris & Harris Group
Pfizer Venture Investments
Rho Ventures
undisclosed
03/02/15 $35,000,000 Series B-1 Elliott Sigal
Pfizer Venture Investments
Rock Springs Capital
undisclosed
06/16/16 $33,000,000 Series C Arrowpoint Partners
Cormorant Asset Management
Takeda Pharmaceutical Company
Wellington Management Company
undisclosed